Healthcare provider profile · identity verified

Lenox Kyle Morris, M.D.

Family Practice · MONROE, GA · NPI 1215010707

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	767	215
Levothyroxine Sodium	Levothyroxine Sodium	698	180
Atorvastatin Calcium	Atorvastatin Calcium	655	186
Losartan Potassium	Losartan Potassium	481	136
Tamsulosin Hcl	Tamsulosin Hcl	433	113
Lisinopril	Lisinopril	389	109
Metformin Hcl	Metformin Hcl	371	99
Pravastatin Sodium	Pravastatin Sodium	371	95
Pantoprazole Sodium	Pantoprazole Sodium	310	105
Gabapentin	Gabapentin	302	90
Omeprazole	Omeprazole	278	84
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	273	81
Potassium Chloride	Potassium Chloride	224	69
Montelukast Sodium	Montelukast Sodium	205	50
Trazodone Hcl	Trazodone Hcl	201	51
Furosemide	Furosemide	196	66
Metoprolol Tartrate	Metoprolol Tartrate	189	52
Albuterol Sulfate Hfa	Albuterol Sulfate	169	66
Prednisone	Prednisone	167	127
Januvia	Sitagliptin Phosphate	160	34
Famotidine	Famotidine	159	45
Eliquis	Apixaban	158	30
Cefdinir	Cefdinir	156	131
Metformin Hcl Er	Metformin Hcl	155	47
Citalopram Hbr	Citalopram Hydrobromide	154	46
Glipizide	Glipizide	154	37
Hydrochlorothiazide	Hydrochlorothiazide	150	45
Simvastatin	Simvastatin	150	42
Sertraline Hcl	Sertraline Hcl	143	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	36
Meloxicam	Meloxicam	129	44
Diclofenac Sodium	Diclofenac Sodium	128	33
Metoprolol Succinate	Metoprolol Succinate	128	41
Rosuvastatin Calcium	Rosuvastatin Calcium	125	40
Carvedilol	Carvedilol	120	33
Atenolol	Atenolol	117	36
Fenofibrate	Fenofibrate	115	30
Allopurinol	Allopurinol	113	32
Fluticasone Propionate	Fluticasone Propionate	109	50
Jardiance	Empagliflozin	109	29
Clopidogrel	Clopidogrel Bisulfate	108	26
Glipizide Er	Glipizide	103	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	97	28
Doxycycline Hyclate	Doxycycline Hyclate	90	57
Clonazepam	Clonazepam	89	23
Donepezil Hcl	Donepezil Hcl	84	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	19
Ozempic	Semaglutide	83	18
Methylprednisolone	Methylprednisolone	82	70
Azithromycin	Azithromycin	79	72
Finasteride	Finasteride	76	22
Duloxetine Hcl	Duloxetine Hcl	71	21
Ipratropium Bromide	Ipratropium Bromide	70	25
Lovastatin	Lovastatin	64	15
Alendronate Sodium	Alendronate Sodium	60	16
Tizanidine Hcl	Tizanidine Hcl	60	35
Zolpidem Tartrate	Zolpidem Tartrate	54	15
Hydralazine Hcl	Hydralazine Hcl	53	12
Memantine Hcl	Memantine Hcl	53	17
Oxybutynin Chloride	Oxybutynin Chloride	53	13
Xarelto	Rivaroxaban	53	suppressed
Clonidine Hcl	Clonidine Hcl	52	18
Ropinirole Hcl	Ropinirole Hcl	50	13
Escitalopram Oxalate	Escitalopram Oxalate	49	15
Fluoxetine Hcl	Fluoxetine Hcl	47	23
Paroxetine Hcl	Paroxetine Hcl	47	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Ondansetron Hcl	Ondansetron Hcl	46	35
Trulicity	Dulaglutide	46	suppressed
Pregabalin	Pregabalin	45	suppressed
Synthroid	Levothyroxine Sodium	44	13
Verapamil Er	Verapamil Hcl	43	suppressed
Meclizine Hcl	Meclizine Hcl	42	22
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Bupropion Xl	Bupropion Hcl	41	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	36
Mirtazapine	Mirtazapine	38	11
Valsartan	Valsartan	38	12
Glimepiride	Glimepiride	36	12
Testosterone	Testosterone	36	suppressed
Buspirone Hcl	Buspirone Hcl	34	15
Lansoprazole	Lansoprazole	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	24
Celecoxib	Celecoxib	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	30	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	11
Ezetimibe	Ezetimibe	26	12
Valacyclovir	Valacyclovir Hcl	26	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	22
Ketoconazole	Ketoconazole	25	16
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Amoxicillin	Amoxicillin	23	16
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Mounjaro	Tirzepatide	19	suppressed
Dutasteride	Dutasteride	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Nystatin	Nystatin	17	11
Primidone	Primidone	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Cephalexin	Cephalexin	14	13
Febuxostat	Febuxostat	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levofloxacin	Levofloxacin	13	12
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lorazepam	Lorazepam	12	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Estradiol	Estradiol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Levemir	Insulin Detemir	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error